SpeeDx Receives CE-IVD Mark for ResistancePlus™ MG

News   Sep 22, 2016

 
SpeeDx Receives CE-IVD Mark for ResistancePlus™ MG
 
 
 
 

RELATED ARTICLES

Biofortuna Raises £1.6 Million in Funding Round

News

Biofortuna Ltd has raised £1.6 million, allowing the company to take its blood group genotyping assays into clinical trails and commercialisation.

READ MORE

UVA Health Enlists Robotic Help to Enhance Blood Testing

News

The system has revolutionized how it tests patient blood samples, automating its primary testing facility with high-tech robots that are getting doctors the results they need quickly and efficiently – and allowing UVA to offer a wider range of blood tests, to boot.

READ MORE

MRSA Survival Chances Predicted by DNA Sequencing

News

Sequencing the DNA of the MRSA superbug can accurately identify patients most at risk of death and could help medics develop new treatments as we move towards personalised medicine.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE